Literature DB >> 35899242

Alloimmune versus autoimmune hepatitis following liver transplantation.

Claire R Harrington1, Josh Levitsky1.   

Abstract

Content available: Audio Recording.
© 2022 American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 35899242      PMCID： PMC9306487          DOI： 10.1002/cld.1234

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  10 in total

1.  Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon.

Authors:  Josh Levitsky; Maria Isabel Fiel; John P Norvell; Edward Wang; Kymberly D Watt; Michael P Curry; Sumeet Tewani; Timothy M McCashland; Maarouf A Hoteit; Abraham Shaked; Samuel Saab; Amanda C Chi; Amy Tien; Thomas D Schiano
Journal:  Gastroenterology       Date:  2012-01-25       Impact factor: 22.682

2.  Rapamycin successfully treats post-transplant autoimmune hepatitis.

Authors:  Nanda Kerkar; Christina Dugan; Carolina Rumbo; Raffaella A Morotti; Gabriel Gondolesi; Benjamin L Shneider; Sukru Emre
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

3.  2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Authors:  A J Demetris; C Bellamy; S G Hübscher; J O'Leary; P S Randhawa; S Feng; D Neil; R B Colvin; G McCaughan; J J Fung; A Del Bello; F P Reinholt; H Haga; O Adeyi; A J Czaja; T Schiano; M I Fiel; M L Smith; M Sebagh; R Y Tanigawa; F Yilmaz; G Alexander; L Baiocchi; M Balasubramanian; I Batal; A K Bhan; J Bucuvalas; C T S Cerski; F Charlotte; M E de Vera; M ElMonayeri; P Fontes; E E Furth; A S H Gouw; S Hafezi-Bakhtiari; J Hart; E Honsova; W Ismail; T Itoh; N C Jhala; U Khettry; G B Klintmalm; S Knechtle; T Koshiba; T Kozlowski; C R Lassman; J Lerut; J Levitsky; L Licini; R Liotta; G Mazariegos; M I Minervini; J Misdraji; T Mohanakumar; J Mölne; I Nasser; J Neuberger; M O'Neil; O Pappo; L Petrovic; P Ruiz; Ö Sağol; A Sanchez Fueyo; E Sasatomi; A Shaked; M Shiller; T Shimizu; B Sis; A Sonzogni; H L Stevenson; S N Thung; G Tisone; A C Tsamandas; A Wernerson; T Wu; A Zeevi; Y Zen
Journal:  Am J Transplant       Date:  2016-07-14       Impact factor: 8.086

4.  Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor.

Authors:  Khawar Abbas; Muhammed Mubarak; Mirza Naqi Zafar; Wajiha Musharraf; Mehjabeen Imam; Tahir Aziz; Adibul Hassan Rizvi
Journal:  Exp Clin Transplant       Date:  2018-03-09       Impact factor: 0.945

5.  Liver transplantation for autoimmune hepatitis.

Authors:  D J Reich; I Fiel; J V Guarrera; S Emre; S R Guy; M E Schwartz; C M Miller; P A Sheiner
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

6.  Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy.

Authors:  Christine Chan; Thomas Schiano; Eliana Agudelo; John Paul Haydek; Maarouf Hoteit; Marcela P Laurito; John P Norvell; Norah Terrault; Elizabeth C Verna; Amy Yang; Josh Levitsky
Journal:  Am J Transplant       Date:  2018-08-30       Impact factor: 8.086

7.  Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.

Authors:  Aya Miyagawa-Hayashino; Hironori Haga; Hiroto Egawa; Yasuaki Hayashino; Takaki Sakurai; Sachiko Minamiguchi; Koichi Tanaka; Toshiaki Manabe
Journal:  Transplantation       Date:  2004-07-15       Impact factor: 4.939

8.  Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation.

Authors:  Isabel Aguilera; Jose M Sousa; Francisco Gavilán; Angel Bernardos; Ingeborg Wichmann; Antonio Nuñez-Roldán
Journal:  Liver Transpl       Date:  2004-09       Impact factor: 5.799

9.  Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.

Authors:  M Isabel Fiel; Kaushik Agarwal; Carmen Stanca; Nassim Elhajj; Nikolas Kontorinis; Swan N Thung; Thomas D Schiano
Journal:  Liver Transpl       Date:  2008-06       Impact factor: 5.799

10.  Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.

Authors:  Cara L Mack; David Adams; David N Assis; Nanda Kerkar; Michael P Manns; Marlyn J Mayo; John M Vierling; Mouaz Alsawas; Mohammad H Murad; Albert J Czaja
Journal:  Hepatology       Date:  2020-05-12       Impact factor: 17.425
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.